EXCLUSIVE: An interview with Buckhaults about DNA contamination in covid vaccines... and the FDA responds
EXCLUSIVE: An interview with Buckhaults about DNA contamination in covid vaccines... and the FDA responds
Earlier this year, genomics expert Kevin McKernan first discovered DNA contamination in vials of Pfizer and Moderna’s bivalent booster shots. He published his findings in a pre-print, but the research received little attention from the mainstream media.
Observing from afar was Phillip Buckhaults, a cancer genomics expert, and professor at the University of South Carolina. Initially, he dismissed McKernan’s findings as “conspiracy” and decided to debunk the work by carrying out his own testing on the mRNA vials.
But what Buckhaults discovered shocked him --> McKernan was right! Buckhaults found billions of tiny DNA fragments in Pfizer’s mRNA vaccine, and recently testified about it before a South Carolina Senate hearing - I covered in a previous article.
I presented the findings of Buckhaults and McKernan to the US FDA.
I asked the FDA if it had begun an investigation into the issue of DNA contamination and whether it would review its guidance to industry about residual DNA in vaccines.
I also asked the FDA if it had instructed Pfizer and Moderna to conduct further testing to demonstrate the absence or presence of genome modification and whether it would issue new warnings to the public about the potential risks, now that DNA contamination in the vaccines had been established and replicated.
The FDA responded but did not answer specific questions, nor did it acknowledge the problem of contamination and potential safety issues. In a written statement it said:
The mRNA COVID-19 vaccines authorized or approved for use in the United States are not defined as a gene therapy.
The FDA is confident in the quality, safety, and effectiveness of these vaccines. The agency’s benefit-risk assessment and ongoing safety surveillance demonstrates that the benefits of their use outweigh their risks.
I spoke with Buckhaults about the unfolding events. Our conversation was edited for clarity and brevity.
